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Background: There is increased interest in using commercial providers for improving access to quality malaria
treatment. Understanding their current role is an essential first step, notably in terms of the volume of diagnostics
and anti-malarials they sell. Sales volume data can be used to measure the importance of different provider and
product types, frequency of parasitological diagnosis and impact of interventions. Several methods for measuring
sales volumes are available, yet all have methodological challenges and evidence is lacking on the comparability of
different methods.
Methods: Using sales volume data on anti-malarials and rapid diagnostic tests (RDTs) for malaria collected through
provider recall (RC) and retail audits (RA), this study measures the degree of agreement between the two methods
at wholesale and retail commercial providers in Cambodia following the Bland-Altman approach. Relative strengths
and weaknesses of the methods were also investigated through qualitative research with fieldworkers.
Results: A total of 67 wholesalers and 107 retailers were sampled. Wholesale sales volumes were estimated
through both methods for 62 anti-malarials and 23 RDTs and retail volumes for 113 anti-malarials and 33 RDTs. At
wholesale outlets, RA estimates for anti-malarial sales were on average higher than RC estimates (mean difference
of four adult equivalent treatment doses (95% CI 0.6-7.2)), equivalent to 30% of mean sales volumes. For RDTs at
wholesalers, the between-method mean difference was not statistically significant (one test, 95% CI −6.0-4.0). At
retail outlets, between-method differences for both anti-malarials and RDTs increased with larger volumes being
measured, so mean differences were not a meaningful measure of agreement between the methods. Qualitative
research revealed that in Cambodia where sales volumes are small, RC had key advantages: providers were
perceived to remember more easily their sales volumes and find RC less invasive; fieldworkers found it more
convenient; and it was cheaper to implement than RA.
Discussion/conclusions: Both RA and RC had implementation challenges and were prone to data collection
errors. Choice of empirical methods is likely to have important implications for data quality depending on the
study context.
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In many low- and middle-income countries, the private
commercial sector plays an important role in the
provision of malaria treatment [1-6]. A study on the
market for anti-malarial drugs in six developing coun-
tries found that private providers were responsible for
around 40% of all anti-malarial sales volumes in Zambia,
55% in Uganda, 71% in Cambodia, and 75% in both
Benin and the Democratic Republic of Congo and 98%
in Nigeria [2]. Their popularity is commonly attributed
to convenience as they tend to operate closer to homes
[7-10], and availability and reliability of drug stocks
compared to public health providers [8,9,11-14]. Private
providers vary substantially within and across countries
and can include hospitals, clinics, pharmacies, drug
shops, grocery stores, village shops, market stalls and
mobile providers.
Given the importance of private commercial outlets,
there has been increased interest in analysing their role
in treatment provision and how this can be improved. A
key aspect of this is the measurement of anti-malarial
and diagnostic sales volumes. Sales volumes data can be
used to calculate market shares and provide information
on the relative importance of public and private sectors
and how this varies across countries. These data can also
be used to estimate the share of recommended first-line
drugs or banned drugs, such as oral artemisinin mono-
therapy, sold in the market [1,2,15]. Data on sales of
rapid diagnostic test kits for malaria can indicate the low
frequency of parasitological-based diagnosis of malaria
fevers [1]. Anti-malarial sales volumes have been mea-
sured to evaluate the effect of major drug subsidy
programmes, such as the Affordable Medicine Facility-
malaria (AMFm) for which the change in the market
share of quality assured artemisinin combination therapy
(ACT) was one of four key success metrics, alongside
availability, price and use [15]. Finally, market share data
can be used for assessing the nature of competition in
the market for malaria treatment and its relationship
with key retail market outcomes, notably anti-malarial
prices and price mark-ups. For example, research on the
market for malaria treatment in Tanzania and Cambodia
has shown that market concentration measured using
the Hirshman-Herfindahl index (HHI) (the sum of
squared market shares of each firm in the market) is re-
lated to the extent to which providers can influence the
price of anti-malarial drugs sold in the market [16,17].
A number of methods for measuring sales volumes
have been identified, namely reviewing providers’ sales
records, asking providers to recall their sales volumes
over a given period, conducting exit interviews with cus-
tomers, and retail audits. Retail audits involve visiting a
panel of outlets to collect stock information at regular
intervals; at each visit, fieldworkers measure the stocksof an entire product category and ask the shopkeeper
about any volumes added and/or disposed of during the
visit interval. The volume of sales for each shop during
the period is then estimated by subtracting the stock at
the end of the period from the stock at the initial visit,
corrected by any additions/disposals during the period.
These data collection methods each have methodo-
logical challenges for collecting commercial sales volume
data at private businesses in developing country settings.
Providers’ sales records may be non-existent, incomplete
and/or outdated. Private commercial providers may be
reluctant to share their sales records as they may fear
that these could be disclosed to drug regulation bodies,
revenue authorities or competitors. Asking providers to
recall their volumes is a convenient and popular method
used in many surveys [18], but it may be prone to recall
bias. Providers may also be unwilling to record or recall
the sales of products that they are not authorized to
handle. The retail audit approach could be perceived to
provide more accurate responses as it does not rely on
respondents’ ability to remember their sales volumes.
However, as it requires at least two visits to the same
outlets within a given period it is likely to be more costly
and logistically complex than relying on records or pro-
vider recall. Exit interviews may be another approach to
address this problem, although the presence of inter-
viewers may bias sales patterns. Shopkeepers may also
not allow interviewers to stand outside their shops or
consumers may be reluctant to share information about
their purchases or they may be in a rush leaving the
shop. Overall, the available approaches tend to be better
suited for estimating the sales of licensed rather than
unlicensed outlets [19] and sales of registered rather
than unregistered products.
Whilst the challenges of these different methods have
been identified, what is lacking is evidence on how sales
volume estimates collected through different methods
in the same context compare. Furthermore, the avail-
able literature concentrates mainly on retail medicine
providers, yet drug retailers are the last link in a chain
of suppliers, including several layers of wholesalers.
Much less attention has been paid to this market seg-
ment [20] and guidance on how to study wholesalers,
notably on how best to collect their sales volume data,
is scarce [17,18].
Using sales volume data collected at retail and whole-
sale outlets through two different methods, namely pro-
vider recall and retail audits, this paper provides
evidence on the degree of agreement between the two
methods in Cambodia. The study was undertaken with
retail and wholesale providers as part of the ACTwatch
project [18], which measured sales volumes using the re-
call method. Retail audits were selected as the compara-
tive method because they had been used for measuring
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[16,21]. Written records were not included in the study
due to their rarity among less formal providers. Exit in-
terviews were not included because anti-malarials repre-
sented a small share of wholesalers’ total business [17],
implying that interviewers may have had to wait many
days outside a shop before identifying a wholesale anti-
malarial customer.
At the time of the study, there were three categories of
licensed medicine outlets in Cambodia, including phar-
macies that were managed by a pharmacist, and dépots
managed by an assistant pharmacist (dépot A) or a re-
tired public health staff member (dépot B) with a mini-
mum qualification of nurse or midwife [17]. Pharmacies
were authorized to engage in both wholesale and retail
activities whilst dépots were authorized to retail only
[17]. Licensed providers were authorized to sell regis-
tered pharmaceutical drugs, hygienic and cosmetic prod-
ucts with preventive and curative properties, and dental,
laboratory and medical equipment. At the time of the
study, there were no clear regulations on the sales of
malaria diagnostics, such as rapid diagnostics tests
(RDTs). Around 520 pharmacies and 695 dépots were
estimated to operate in Cambodia, supplemented by
many other medicine sellers that operated illegally, in-
cluding unlicensed pharmacies and drug shops that sold
medicines, cosmetics and household goods; private
clinics (sometime referred to as cabinets or clinical phar-
macies) that sold medicines and also provided outpatient
and/or inpatient clinical services; mobile providers who
travelled to patients’ homes to provide clinical services,
and at times offered outpatient and/or inpatient care at
fixed outlets; and, grocery and village shops that sold
medicines alongside food, soft drinks and other con-
sumer goods [1,22].
Methods
Sales volume data for anti-malarials and RDTs were col-
lected through the recall (RC) and the retail audit (RA)
methods, together referred to as the sales level surveys
(SLS) in retail and wholesale commercial anti-malarial
providers. The aim of the SLS was to explore whether
RC and RA for measuring sales volumes agreed suffi-
ciently that they can be used interchangeably. The rela-
tive strengths and weaknesses of each method were also
analysed from an implementation perspective using
qualitative methods.
The sales level surveys
RA consisted of visiting each sampled outlet two times
with a two-week time interval between each visit. At the
first visit, referred to as the sales level survey 1 (SLS1),
data on quantities stocked of each product were col-
lected. At the second visit (SLS2), data on quantitiesstocked, quantities delivered between first (SLS1) and
second (SLS2) visits, and quantities thrown away/trans-
ferred to other shops or sent back to wholesalers or con-
fiscated were collected for each product in stock,
including products in stock at either or both visits.
Quantities stocked were physically counted where pos-
sible or providers were asked to state the quantities in
stock. To collect data on quantities delivered and dis-
posed of, providers were asked to check any available
written records or sales receipts and in the absence of
records, to recall these quantities. RC consisted of asking
retailers and wholesalers to recall the quantities sold
during the two-week time interval between SLS1 and
SLS2. It was implemented at the start of SLS2 before
collecting stock data in order to minimize bias as recall
data may have been influenced by the process of
counting stocks for the RA. A time interval of two weeks
between the two visits at each outlet was chosen based
on the existing literature in which a two-week time
interval was considered reasonable for capturing whole-
sale deliveries [16,21]. A recall period of two weeks has
also generally been used for collecting data such as fever
episodes in household surveys [23-25].
The SLS sampling strategy drew on data collected dur-
ing the ACTwatch retail outlet and supply chain surveys,
which are described in detail elsewhere [18]. Briefly, for
the ACTwatch retail outlet survey, a sample of 38 ad-
ministrative clusters (health centre areas with catchment
populations of 10–15,000 inhabitants) were selected with
probability proportional to size from all 255 malaria en-
demic clusters in Cambodia [1]. Then, a census of all
public and private outlets in these 38 clusters was com-
pleted and a list of those stocking anti-malarial drugs
was created [1]. At each retail outlet, data were collected
on the two most important wholesale supply sources
for anti-malarial drugs. All anti-malarial wholesale sup-
ply sources mentioned by retailers were visited during
the ACTwatch supply chain study. Data were collected
on the two most important wholesale supply sources.
This process was then repeated until the top of the chain
was reached.
For the SLS, retail and wholesale outlets were purpos-
ively sampled from the list of anti-malarial retailers and
wholesalers surveyed during the ACTwatch surveys. The
geographical location of each commercial outlet and the
number of outlets stocking anti-malarials in each loca-
tion at the time of the outlet survey were used to select
areas in which all outlets could be visited two times with
a two-week time interval (in order to conduct the RA
component).
A total of 107 retailers and 67 wholesale outlets were
sampled. Wholesale and retail outlets not found, not
stocking anti-malarials or not available at the time of the
SLS were not replaced.
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survey few months after the ACTwatch retail outlet sur-
vey. At wholesale level, the SLS took place during the
ACTwatch supply chain survey. The questions relating
to SLS1 (questions about quantities stocked) were asked
after the supply chain survey questionnaire was adminis-
tered, whilst SLS2 (questions about recall sales volumes,
quantities stocked and quantities received and disposed
of ) was conducted two weeks later as a standalone
survey.
All data collection tools were translated from English
to Khmer and piloted before the start of data collection.
A team of two interviewers entered each business, in-
formed shopkeepers about the study objective and
obtained consent. Interviews were conducted in Khmer,
with the person most involved in the management of the
business. Interviews were conducted in the premises,
with breaks each time a customer arrived. Interviewers
then asked whether they could return after two weeks
and if so they arranged an appointment, and returned
on that date.
All types of anti-malarial drugs in all dosage forms and
packaging types, and RDTs were surveyed. For anti-
malarials, data were collected in terms of both full packs
and loose tablets (ie, those kept in containers/tins).
Stock data for anti-malarials stored in half-full con-
tainers were estimated based on the height of the tablets
in the pot measured using a ruler and the number of
tablets in a full pot. RDT data were collected in terms of
single RDT units.
For each anti-malarial observation, volume estimates
were converted into adult equivalent treatment doses
(AETDs) [1]. One AETD was defined as the amount of
the drug needed for a full adult course of treatment based
on guidelines from the World Health Organization
(WHO) where available, or else from peer-reviewed litera-
ture or manufacturers. Anti-malarials missing data re-
quired to calculate AETDs (eg, drug strength) were
excluded from the sales volume estimation [1].
RA estimates were calculated as: (total quantities
stocked at SLS1) + (quantities delivered between SLS1
and SLS2) – (quantities disposed of between SLS1 and
SLS2) – (total quantities stocked at SLS2).
Negative RA estimates indicating data collection errors
during the SLS and anti-malarial/RDT observations
without both RA and RC estimates were excluded from
the analysis.
In outlets with sales data for more than one type of
anti-malarial/RDT the sum of all RC estimates and of
all RA estimates was calculated in order to obtain for
each outlet single total sales volume estimates with
each method.
The level of agreement between the two methods was
explored following the Bland-Altman approach [26,27].The first step was to calculate, for each outlet, the dif-
ference between RA and RC sales volume estimates for
outlet i. Formally:
RAi‐RCi ðaÞ
where RAi and RCi are sales volumes estimated through
the two different methods at outlet i.
The second step was to estimate the “bias of the meas-
urement” between the two methods, which is the mean of
the differences between the two different methods (b1),















where xi ¼ RAi‐RCið Þ is the difference between RA and
RC in outleti x ¼ RA‐RC― the mean of the differences be-
tween RA and RC across all outlets and n the total num-
ber of outlets with a pair of RA and RC estimates.
Differences between sales volume estimates were plot-
ted on a histogram (not shown) to verify that they were
approximately normally distributed.
The third step was to investigate for each outlet whether
there was an association between the total volume sold
and the bias (ie, the mean of the difference, b1). This is be-
cause for the bias to be a meaningful estimate of the level
of agreement between the two different methods, it should
be constant throughout the range of measurements
[26,27]. In the absence of a recognized gold standard
method for measuring sales volumes, an outlet’s “true”





The association between total volume sold (c) and meas-
urement bias (b1) was explored graphically using a scatter
plot of the differences against total volume sold and con-
firmed statistically using a correlation coefficient obtained
through the STATA command baplot [28].
The fourth step was to calculate the interval within
which 95% of paired estimates were expected to lie, re-
ferred to as the upper and lower limits of agreement
(LoA) between the two methods [26]. Formally:
LoA ¼ RA‐RC―  1:96SD ðdÞ
Qualitative methods
The quantitative analysis was supplemented by qualita-
tive data on information about the implementation
process of RC and RA. Qualitative data were drawn from
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end of each outlet visit. In each diary, fieldworkers de-
scribed and compared their experiences in collecting
data across RC and RA, products, dosage forms and
packaging types. They also recorded observations of
shopkeepers’ behaviour during data collection.
Semi-formal group discussions were also organized dur-
ing the course of the fieldwork to clarify diary entries.
These discussions provided a forum for fieldworkers to
elaborate on particular topics, share arduous experiences,
discuss their views and trade funny stories. Group discus-
sions also had the advantage of creating interactions be-
tween fieldworkers, which prompted others to remember
their own experiences [29]. Group discussions were facili-
tated in English and/or Khmer by the corresponding au-
thor with the assistance of a trained Cambodian research
assistant and recorded using written notes. Five group dis-
cussions were conducted at the mid and end of data col-
lection with each of the three fieldworker teams involved
in the SLS. Fieldwork diaries kept in Khmer were trans-
lated into English by a trained research assistant. These
data were analysed using a simple thematic content ap-
proach through which recurrent themes under each of the
topics discussed were listed and compared.
Ethics considerations
The study received ethics clearance from the Cambodian
National Ethics Committee for Health Research (no. 041
NECHR) and ethics review committee of the LSHTM
(no. 5466).
Informed consent from each interviewed shopkeeper
was obtained at SLS1 to cover both SLS visits. For diar-
ies and group discussions, fieldworkers’ participation as
research subjects was explained during the recruitment
process and consent received orally from each field-
worker recruited.
Results
Quantitative results: Bland-Altman approach
Of the 67 wholesalers and 107 retailers initially sampled,
58 and 62% participated in the SLS, respectively. Rea-
sons for non-participation at both wholesale and retail
outlets at SLS1 included outlets not found, not open at
the time of visit or not stocking anti-malarial drugs,
whilst at SLS2 the main reason for non-participation
was provider refusal. The SLS wholesale sample was
similar to that surveyed during the nationally represen-
tative ACTwatch supply chain survey: outlets had a me-
dian of two workers (IQR 2–2), had been in operation
for 10 years (IQR 4–13) and around 70% employed a
member of staff with health qualifications, with nurse/
midwife being the most commonly reported qualification
type [17]. The SLS sample of retailers included pharmacies/
clinical pharmacies (13%), drug shops (21%), mobileproviders (20%), grocery stores (26%) and village shops
(20%). Retailers shared similar characteristics with those of
the commercial outlets interviewed during the ACTwatch
outlet survey: staff with health qualifications were more
commonly found at pharmacies (85%), drug shops (76%)
and mobile providers (70%) than at grocery and village
shops (13 and 12%, respectively), and the most commonly
reported health qualifications were nurses/midwives. A me-
dian of two people (IQR 1–2) worked at the sampled out-
lets and shops had been in operation for a median of eight
years (IQR 2–15) [17]. Surveyed anti-malarials were found
in tablet and injectable forms only. Tablets were commonly
stocked in packs, and injectables in individual ampoules.
Tablets kept in opened tins/containers were rare and found
at retail outlets only.
At wholesale outlets, 104 different anti-malarial prod-
ucts were surveyed. Sales volumes were collected for 76
anti-malarial products through RC and for 82 through
RA (Table 1). For RDTs, 34 different products were sur-
veyed and sales volumes were collected for 26 products
through the RC and for 29 through the RA. The main
reasons for non-response included wholesalers’ refusal
to recall their sales volumes for the RC, and for the RA
wholesalers’ refusal to let interviewers record stock
data (Table 1). Wholesale sales volumes were estimated
through both RC and RA for 62 anti-malarials and
23 RDTs.
At retail outlets, 143 anti-malarial products were sur-
veyed. Sales volume data were collected through the RC
for 130 anti-malarial products and through the RA for
115 anti-malarial products (Table 1). For RDTs, 42 dif-
ferent products were surveyed and sales volumes were
collected for 41 through the RC and for 35 through the
RA (Table 1). Retail sales volumes were estimated
through both RC and RA for 113 anti-malarials and 33
RDTs.
RC and RA sales volume estimates were obtained for
34 wholesale outlets when considering anti-malarials
and 23 wholesale outlets when considering RDTs. Simi-
larly, estimates were obtained for 58 retail outlets when
considering anti-malarials and 33 outlets when consider-
ing RDTs. At one retail outlet, the total volume sold was
surprisingly high and well above other retailers’ total
sales volumes (outlier outlet total sales volume esti-
mated at 129 AETDs compared to volumes at all other
retail outlets ranging from 0 to 20 AETDs). This outly-
ing observation obscured the interpretation of results
so it was excluded from the main analysis, which was
run on paired anti-malarial estimates available for 57
retail outlets.
Figure 1 presents the scatter plots showing on the
y-axis the between-method differences, and on the
x-axis the mean of the sales volume obtained by the two
methods for the outlet. The dashed blue line drawn at
Table 1 Data collected on wholesale and retail sales volumes using recall and retail audit methods
Number of products surveyed (%)1
Wholesale SLS Retail SLS
Anti-malarials RDT Anti-malarials RDT
Total products surveyed 104 (100%) 34 (100%) 143 (100%) 42 (100%)
Recall method (RC)
Sales volume data collected 76 (73.1%) 26 (76.5%) 130 (91.0%) 41 (97.6%)
- Not remembered 17 (16.3%) 7 (21.6%) 3 (2.8%) 1 (2.4%)
- Refused 11 (10.6%) 1 (2.9%) - -
- Missing2 - - 10 (7.0%) -
Retail Audit method (RA)
Sales volumes data calculated (excluding negatives) 82 (78.8%) 29 (85.3%) 115 (80.4%) 35 (83.3%)
Sales volumes data calculated (including negatives)3 94 (90.4%) 31 (91.2%) 121 (84.6%) 39 (92.9%)
Stock data collected 96 (92.3%) 31 (91.2%) 121 (84.6%) 39 (92.9%)
- Refused 8 (7.7%) 3 (8.8%) 12 (8.4%) 3 (7.1%)
- Missing2 - - 10 (7.0%) -
Received quantities collected 103 (99.0%) 33 (97.1%) 133 (93.0%) 42 (100.0%)
- Refused 1 (1.0%) 1 (2.9%) - -
- Missing2 - - 10 (7.0%)
Disposed quantities collected 101 (97.1%) 33 (97.1%) 133 (93.0%) 42 (100.0%)
- Refused 3 (2.9%) 1 (2.9%) - -
- Missing2 - - 10 (7.0%)
1At the second visit of RA during which RC was implemented. 2missing strength data impeded calculation of data in terms of adult equivalent treatment doses.
3negative sales volume estimates were obtained when calculating (quantities in stock at 1st visit + quantities received in-between the 2 visits – quantities at 2nd
visit – quantities disposed in-between the 2 visits), e.g. quantities stocked at second visit were higher than quantities stocked at first visit although shopkeepers
did not report any quantities received. These negative estimates were excluded from the analysis.
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measured by the two methods. The mean of the
between-method differences is represented by the red
line and the LoA between the two methods are repre-
sented by the two dashed red lines.
Figure 1a shows no evidence of correlation between the
between-method differences and the size of the volumes
sold for wholesale anti-malarial sales. This was confirmed
by a coefficient of correlation r = −0.04 (p = 0.83). The
mean difference between RA and RC estimates for anti-
malarials was four AETDs indicating that RA provided on
average significantly higher estimates than RC (95% CI
0.6-7.2). The LoA indicated that for 95% of paired esti-
mates the between-method difference (RA minus RC)
would lie between plus 23 AETDs (95% CI 16.0-28.0) and
minus 15 AETDs (95% CI −20.4- -9.0). For RDT sales vol-
umes at wholesale outlets, Figure 1c shows no evidence of
correlation between the between-method differences and
volumes sold (r = 0.04, p = 0.86) and no significant differ-
ence between RC and RA estimates (95% CI −6.0-4.0).
The LoA were from plus 22 to minus 21 tests.
At retail outlets, there was some indication from
Figures 1b and 1d that the between-method differences
were positively correlated with volumes sold (for anti-
malarials r =0.49, p < 0.001; RDTs r =0.38, p = 0.03).When including the outlet with the outlying anti-
malarial sales volume the evidence of a correlation
between the between-method differences and sales
volumes was also statistically significant and stronger
(r = 0.823, p < 0.001; mean difference was two AEDTs
(95% CI 0.23-4.0) and LoA were from plus 16 AEDTs to
minus 12 AETDs). The mean difference cannot there-
fore be considered a meaningful estimate of the level of
agreement between the two different methods. However,
Figures 1b and 1d seem to indicate that RA tended to
provide higher estimates than RC at higher levels of sales
volumes (around above five AETDs for anti-malarials
and 10 units for RDT).
Qualitative results: fieldworkers’ experiences and
perceptions
Data collectors found the RC to be a more convenient
approach than RA for collecting sales volume data, not-
ably at retail outlets where shopkeepers said they rarely
had customers for malaria treatment. Data collectors
also mentioned that retailers seemed to be more com-
fortable remembering sales volumes of RDTs than anti-
malarials and that this was because performing a malaria
test was a more memorable and discrete event than
selling anti-malarials. However, data collectors often
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Figure 1 Scatter plots of the between-method differences (RA-RC) against mean volumes of sales measured. A. Between-method
differences (RA-RC) against volumes measured for anti-malarial sold at wholesale outlets. B. Between-method differences (RA-RC) against volumes
measured for anti-malarials sold at retail outlets. C. Between-method differences (RA-RC) against volumes measured for RDTs sold at wholesale
outlets. D. Between-method differences (RA-RC) against volumes measured for RDTs sold at retail outlets. RC: recall, RA: retail audit, RDTs: rapid
diagnostic tests, AETD: Adult Equivalent Treatment Dose.
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lected both at retail and wholesale outlets.
“She said: “it might be like this, [or] it may be like
that””. (Fieldwork diary #1 about RC implemented
at a retail outlet).
“She might have misreported her sales volumes,
because I saw five empty boxes of anti-malarials near
her”. (Fieldwork diary #5 about RC implemented
at a wholesale outlet).
Data collectors indicated that when shopkeepers could
not remember their sales volumes, this was because they
often handled other consumer goods, including toiletries
or groceries, which were their main selling items. An-
other reason was that more than one person worked atthe shop, making it difficult for respondents to provide
accurate estimates. Fieldworkers also said that they per-
ceived wholesalers to be less capable of remembering
their sales volumes because they generally handled a
wider range of drugs and sold larger volumes.
Data collectors reported that during the RA counting
stocks was relatively easy and quick because of the
small range of anti-malarials and RDTs available at each
outlet. They also reported that counting RDTs tended
to be easier than anti-malarials, especially when anti-
malarials were kept in opened tins. For example, one
interviewer explained that in one shop the tin was not
transparent, preventing him from using a ruler so that
he had to count each tablet left in the tin. Also, at
times, interviewers reported they had estimated more
pills in the tin at the second than at the first visit al-
though shopkeepers said that no new tin had been
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on quantities received and disposed of shopkeepers re-
membered generally very easily because the reported
quantities were generally small and often null. They
also reported that shopkeepers were generally surprised
to be asked about disposed quantities because they said
that they never throw products away nor send these
back to suppliers.
However, data collectors reported important chal-
lenges around the implementation of RA. First, they in-
dicated that both wholesalers and retailers refused at
times to let interviewers physically count the quantities
in stock, with this challenge occurring more commonly
at wholesale than retail outlets.
“They did not allow us to count and they did not
want to count for us at all […] they said they didn’t
want to spend time with us […] they said that it
[the survey] was useless and wasting their time”
(Fieldwork diary #40 about RA implemented at
a wholesale outlet).
“She claimed that I asked the same question at first
visit. She said that I should write the same amount as
at first visit”. (Fieldwork diary #2 about RA
implemented at a wholesale outlet).
Second, data collectors reported that in many cases
shopkeepers preferred to estimate their stock from
memory, rather than have these counted. Fieldworkers
added that this situation was again more common
amongst wholesalers who often refused to let inter-
viewers open the cupboards where they kept the
drugs.
This was corroborated by the SLS quantitative data,
which showed that at SLS1 stocks of anti-malarial drugs
were physically counted for around 51% of all anti-
malarial products surveyed at wholesale outlets com-
pared to 97% at retail outlets. In outlets where stocks
could not be physically counted, quantities stocked were
stated by wholesalers. In some cases, data collectors
explained that the quantities stocked were estimated by
memory due to factors beyond the control of shop-
keepers. For example, one wholesaler was said to be
refurbishing his shop at first visit so that it was not pos-
sible to proceed to the stock count. In other cases, one
wholesaler and one retailer did not stock all drugs at the
shop premises but at their home so the stock count
could not be performed.
As during RC, data collectors questioned the accuracy
of the data they had recorded during RA. Data collectors
said that in some shops they counted higher quantities
at SLS2 than at SLS1, although no new supplies were re-
portedly received. During a group discussion, a datacollector explained that in one wholesale outlet, the
shopkeeper had prepared an order at first visit (so quan-
tities were not counted as ‘stocked’) but that a few days
later the customer had cancelled the order and the shop-
keeper had put the drugs back on the shelves but forgot
to consider it as a new quantity received.
Last but not least, fieldworkers reported being worn
out by the implementation of RA, because of respon-
dents’ attitudes.
“She blamed me about what the questions asked”
(Fieldworker #1 during a group discussion).
“I could hear that she whispered ‘what the hell they
come again’ ” (Fieldworker #1 during a group
discussion).
Discussion
This study compared two methods for measuring com-
mercial outlet sales volumes, the recall and retail audit
methods. Before discussing the results, some limitations
should be noted. First, the samples were relatively small,
notably at the wholesale level where sales volume observa-
tions were available for 34 outlets in the case of anti-
malarial drugs and for 23 outlets in the case of RDTs. A
second limitation is that whilst negative RA estimates
clearly indicated data collection errors, and were excluded
from the analysis, positive outliers may also have been er-
rors but could not be easily identified. Third, RC estimates
that were compared to RA estimates were collected at
SLS2, which may have contributed to improving their ac-
curacy as shopkeepers who expected a second interview
may have paid more attention to anti-malarial/RDT sales
or may have found it easier to identify the recall period be-
cause the SLS1 was a memorable event.
At wholesale outlets, the analysis did not allow to con-
clude that on average the two methods ‘agreed’. The
mean difference in anti-malarial sales volume estimates
between the two methods was significant and large (four
AETDs, 95% CI 0.2-7.2), equivalent to about 30% of
mean total sales volumes, and 66% of median total sales
volumes. The limits of agreement, which provide an in-
dication of the difference between the measurements at
individual outlets, confirmed that estimates obtained
through RA and RC methods were often quite different.
Overall, for one third of wholesale outlets, the difference
between RA and RC estimates represented as much as
50% of the total sales volumes being measured. For
RDTs, the analysis of sales volumes showed that the two
methods could, on average, be used interchangeably for
estimating average sales: the mean difference was small
(mean 1 test, 95% CI −6.0 to 4.0), equivalent to about
10% of both mean and median total sales volumes, and
overall not statistically significant. However, the study
Patouillard et al. Malaria Journal 2013, 12:311 Page 9 of 11
http://www.malariajournal.com/content/12/1/311lacked power to estimate the difference with sufficient
precision, and the result may be a consequence of the
small sample. Overall, RDT sales volume measures var-
ied greatly at individual outlets, with differences between
RA and RC of more than 50% of the volumes measured
at more than 20% of wholesalers.
At retail outlets, results were more difficult to inter-
pret: bias and limits of agreement were not constant
throughout the range of measurements and the
between-method differences were positively correlated
with volumes, with increasing differences with larger
volumes being measured.
Several reasons may explain the between-method dif-
ferences. At wholesale level, fieldworkers reported that
shopkeepers had difficulty remembering anti-malarial
sales volumes as they generally stocked a wide range
of other products. It is also possible that wholesalers
underestimated their sales volumes during recall for fear
of disclosure to competitors or regulatory authorities. As
indicated in the background section, outlets with a phar-
macy license were authorized to wholesale. However, at
the time of the study, less than 40% of wholesalers
reported holding a pharmacy license allowing them to
wholesale medicines [17]. At retail level, the percentage
of retailers holding a license allowing them to retail was
somewhat higher at 66% [17]. Fieldworkers also experi-
enced some challenges when implementing the RA
method, during which it was not always possible to
count the quantities stocked. At wholesale outlets, the
SLS was implemented at the end of the supply chain
survey questionnaire during which wholesalers were also
asked about their business characteristics and practices
and this may have created fatigue and/or anxiety
amongst both respondents and fieldworkers leading to
data collection errors. RA estimates might have been af-
fected in some cases by “recall” bias for stock data, and
if wholesalers had under-reported their sales volumes
through RC they may well have misreported their stocks
during RA.
At retail outlets, fieldworkers did not report retailers
to have had difficulties remembering their sales volumes
but there were concerns about the accuracy of the RC
data. Furthermore, the higher estimates produced by
RA than RC as sales volumes increased could indicate
that retailers may have had more difficulty accurately
recalling larger sales volumes than smaller ones. If so,
the more accurate measures produced by RA in higher
sales volume contexts may justify the additional re-
sources required for implementing this method. Based
on project expenditure records, the implementation of
RA that required two visits to the same outlet was, as
expected, around twice the total cost of RC, amounting
to US$8,369, equivalent to US$48 per outlet visit or US
$96 per outlet for the two RA visits combined. However,results show that the RA method is also prone to many
data collection errors, and is more complex, time-
consuming and invasive from the perspective of some
commercial providers; these limitations are likely to
jeopardize the quality of RA data collected. Stock-outs
may have affected the results, with RC estimates being
systematically lower than RA as observed at wholesale
and retail levels. However, stock-outs may not be an im-
portant source of bias in measurement of sales volumes,
as generally if a certain drug was not in stock at the time
of visit one would expect its sales volumes to be zero. It
is possible that sales volumes measured by the RC
method may be underestimated if a product was sold
during the recall period but was no longer in stock and,
therefore, not asked about. Similarly for the RA method,
it might be possible to have failed to record sales for a
product that was stocked in between the two visits but
not during either visit, though this is unlikely.
The finding that the choice of method is likely to dra-
matically affect the size of the volumes measured has
important implications if outlet-specific volumes are
needed, for example in the context of an intervention re-
warding individual sellers as a function of volume sold.
In a study of the market for malaria treatment, this
would also have implications if the objective is to meas-
ure market size in terms of volumes purchased.
The feasibility and acceptability of different methods is
also likely to vary across countries. Providers’ willingness
to recall their sales volumes and more generally partici-
pate in a medicine outlet survey may be very variable
across different sociocultural contexts. For instance,
during the ACTwatch supply chain survey, 5% of whole-
salers in Cambodia refused to participate whilst in
Zambia and Nigeria the refusal rate was 2% and 19%
respectively [19,30]. More specifically, whilst anti-
malarials represented a small share of wholesale and re-
tail providers’ businesses in Cambodia, larger and highly
variable volumes were handled in other ACTwatch
countries. For example, the median anti-malarial vol-
umes sold by wholesalers during the week preceding the
supply chain survey ranged from 244 AETDs (IQR 26–
1,104) in Benin, 689 AETDs (IQR 125–1,933) in Zambia
and 1,346 AETDs (IQR 364–4,728) in Nigeria, whilst it
was 0 AETD (IQR 0–0.4) in Cambodia. The suitability
of different methods for measuring sales volumes is
therefore likely to vary across contexts, including the
type of outlets (e g, retail vs wholesale) and country
under study (e g, malaria incidence).
Conclusion
This study is the first that empirically compares two
methods for measuring sales volumes at different anti-
malarial outlet types, including both retail and wholesale
outlets. It showed that at wholesale outlets the two
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for RDT volumes, although the sample size was small
for the latter. At retail outlets, the between-method dif-
ference was not constant throughout the range of meas-
urement, which made the interpretation of results more
difficult. Qualitative research indicated that both RA and
RC methods have implementation challenges and dem-
onstrated that the choice of empirical methods in a re-
search project is likely to have important implications
for the quality of data to be collected. Whilst the analysis
did not provide firm conclusions on which method is
more likely to provide more accurate sales estimates, it
demonstrated that in Cambodia where sales volumes are
relatively small, the RC method appeared to have key ad-
vantages: retailers were perceived to easily remember
their sales volumes, wholesalers were perceived to find
the method less invasive, and fieldworkers found it more
convenient. The RC method was also the cheapest to
implement. However, as mentioned above, sales volumes
in Cambodia are low compared to other malaria-
endemic countries and future research should aim to re-
peat such comparative analysis in contexts where anti-
malarial and RDT sales volumes are larger.
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